-
1
-
-
35348895157
-
-
Amory, John K, Page, Stephanie T, Bremner, William J. Center for Research in Reproduction and Contraception, Divisions of General Internal Medicine and Endocrinology, Metabolism and Nutrition, Department of Medicine, University of Washington Medical School, Seattle, Washington
-
Amory, John K.; Page, Stephanie T.; Bremner, William J. Center for Research in Reproduction and Contraception, Divisions of General Internal Medicine and Endocrinology, Metabolism and Nutrition, Department of Medicine, University of Washington Medical School, Seattle, Washington.
-
-
-
-
3
-
-
35348849247
-
-
EP 0298652 B1, 1989
-
Bhattacharya, A.; Douglas, A.; Grabowski, W.; Edward, D.; Ulf, H. EP 0298652 B1, 1989.
-
-
-
Bhattacharya, A.1
Douglas, A.2
Grabowski, W.3
Edward, D.4
Ulf, H.5
-
4
-
-
35348831284
-
-
Gary, H. R.; Glenn, F. R.; Nathan, G. S.; Edward, W.; Gool, F. P.; Tehming, L.; Margaret, A. C.; Anne, H. C.; Jerry, R. B.; Charles, B. J. Med. Chem. 1986, 29, 2298-2315.
-
(1986)
J. Med. Chem
, vol.29
, pp. 2298-2315
-
-
Gary, H.R.1
Glenn, F.R.2
Nathan, G.S.3
Edward, W.4
Gool, F.P.5
Tehming, L.6
Margaret, A.C.7
Anne, H.C.8
Jerry, R.B.9
Charles, B.10
-
5
-
-
35348888555
-
-
U.S. Patent 4,377,584
-
Gary, H. R.; David, B., R.; Johnston, N. J.; Warren, N. J.; Glen, E. A., U.S. Patent 4,377,584, 1983.
-
(1983)
-
-
Gary, H.R.1
David, B.R.2
Johnston, N.J.3
Warren, N.J.4
Glen, E.A.5
-
6
-
-
2342418009
-
-
(a) Kan, W. M.; Yek, Y. L.; Wang, Y.-H.; Chern, C-Y. Chin. Pharma. J. 2003, 55, 213-219.
-
(2003)
Chin. Pharma. J
, vol.55
, pp. 213-219
-
-
Kan, W.M.1
Yek, Y.L.2
Wang, Y.-H.3
Chern, C.-Y.4
-
7
-
-
0028829541
-
-
(b) Miller, R. A.; Humphrey, G. R.; Thompson, A. S. Tetrahedron Lett. 1995, 36, 7949-7952.
-
(1995)
Tetrahedron Lett
, vol.36
, pp. 7949-7952
-
-
Miller, R.A.1
Humphrey, G.R.2
Thompson, A.S.3
-
8
-
-
35348863265
-
-
U.S. Patent 6,794,508B2, 2004
-
(c) Roman, D.; Alan, M.; Jeffrey, T.S. U.S. Patent 6,794,508B2, 2004.
-
-
-
Roman, D.1
Alan, M.2
Jeffrey, T.S.3
-
9
-
-
35348923069
-
-
(a) www.matthey.com/about/preciousmetal.htm.
-
-
-
-
10
-
-
35348868784
-
-
The other palladium on carbon was procured from Hindustan Platinum Limited
-
(b) The other palladium on carbon was procured from Hindustan Platinum Limited.
-
-
-
-
11
-
-
35348887338
-
-
There are three types of catalysts which were screened for this hydrogenation reaction beside type 39. No reduction was observed using types 5T487, 5T490, or 5T58
-
There are three types of catalysts which were screened for this hydrogenation reaction beside type 39. No reduction was observed using types 5T487, 5T490, or 5T58.
-
-
-
-
12
-
-
35348813908
-
-
The compounds of 2 and 7 are soluble in minimum quantities of acetic acid (Table 2). Hence, acetic acid is directly used as a cosolvent along with methanol during the optimization of solvent quantity.
-
The compounds of 2 and 7 are soluble in minimum quantities of acetic acid (Table 2). Hence, acetic acid is directly used as a cosolvent along with methanol during the optimization of solvent quantity.
-
-
-
-
13
-
-
35348883449
-
-
2, manufactured by Chemee Equipment Pvt. Ltd., Mumbai, India, was used for the reaction.
-
2, manufactured by Chemee Equipment Pvt. Ltd., Mumbai, India, was used for the reaction.
-
-
-
-
14
-
-
35348916138
-
-
18, 250 mm × 4.6 mm, 5 μm. Mobile phase (MP): MP-A, 100% buffer (0.5 g of o-phosphoric acid in 1000 mL of water); MP-B, acetonitrile and water in the ratio of 70:30; 0.8 mL/min; 210 nm. See Table 3 for the gradient profile.
-
18, 250 mm × 4.6 mm, 5 μm. Mobile phase (MP): MP-A, 100% buffer (0.5 g of o-phosphoric acid in 1000 mL of water); MP-B, acetonitrile and water in the ratio of 70:30; 0.8 mL/min; 210 nm. See Table 3 for the gradient profile.
-
-
-
|